The Chemours Company Net Income 2013–2025
The Chemours Company reported $-386.00M of net income for fiscal 2025. That was 548.8% lower than fiscal 2024. Compared with fiscal 2020, the change was -276.3%.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $-386.00M | -6.6% | -548.8% |
| FY 2024 | $86.00M | 1.5% | +136.1% |
| FY 2023 | $-238.00M | -3.9% | -141.2% |
| FY 2022 | $578.00M | 8.5% | -4.9% |
| FY 2021 | $608.00M | 9.6% | +177.6% |
| FY 2020 | $219.00M | 4.4% | +521.2% |
| FY 2019 | $-52.00M | -0.9% | -105.2% |
| FY 2018 | $995.00M | 15.0% | +33.4% |
| FY 2017 | $746.00M | 12.1% | +10557.1% |
| FY 2016 | $7.00M | 0.1% | +107.8% |
| FY 2015 | $-90.00M | -1.6% | -122.5% |
| FY 2014 | $400.00M | 6.2% | -5.4% |
| FY 2013 | $423.00M | 6.2% | — |
Source: The Chemours Company SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CC 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
The Chemours Company reported $-386.00M of net income for fiscal 2025. That was 548.8% lower than fiscal 2024. Compared with fiscal 2020, the change was -276.3%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for The Chemours Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeThe Chemours Company — frequently asked questions
What is The Chemours Company's net income?
The Chemours Company (CC) reported net income of $-386.00M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from The Chemours Company's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.